Statistical controversies in clinical research: should schedules of tumor size assessments be changed?. Filleron T, Kouokam W, Gilhodes J, Duhamel A, Penel N, Joly F, Tresch-Bruneel E, Kramar A, & Houédé N Ann. Oncol., 27:1981-1987, 2016.
Statistical controversies in clinical research: should schedules of tumor size assessments be changed? [link]Paper  doi  bibtex   
@article{filleron_t_statistical_2016,
title = {Statistical controversies in clinical research: should schedules of tumor size assessments be changed?},
volume = {27},
issn = {0923-7534},
url = {http://www.ncbi.nlm.nih.gov/pubmed/27502711},
DOI = {10.1093/annonc/mdw292},
Language = {English},
Journal = {Ann. Oncol.},
author = {{Filleron T} and {Kouokam W} and {Gilhodes J} and {Duhamel A} and {Penel N} and {Joly F} and {Tresch-Bruneel E} and {Kramar A} and {Houédé N}},
year = {2016},
keywords = {Antineoplastic Agents/therapeutic use, Biomedical Research/statistics & numerical data*, Clinical Trials, Phase II as Topic/statistics & numerical data*, Disease Progression, Humans, Neoplasms/drug therapy*, Tumor Burden/drug effects},
pages = {1981-1987}
}
Downloads: 0